|
The RIQAS Epstein Barr Virus quarterly EQA programme is designed to monitor the performance of the parameters listed below.
- Liquid ready to use samples for ease of use and convenience
- 100% human plasma mirrors the performance of patient samples
|
Cat no: |
RQ9153 |
|
Vial size: |
3 x 1ml (samples shipped 4 times per year) |
Frequency: |
Quarterly reporting (1 x 12 month cycle), Quantitative and Qualitative Results |
| Cycle Start Date: |
25 June 2012 (Cycle will run from June 2012 to March 2013) |
Parameters: |
Anti-EBNA IgG
Anti-EBV VCA IgG
Anti-EBV VCA IgM
|
Please contact marketing@randox.com if you would like to participate |